Home
中文
About Us
> CEO Statement
> At a Glance
> Mission and Values
> Global Recognition
> History and Milestones
> Management Team
> Brochure
Therapeutic Focus
> Oncology
> Autoimmune Diseases
Products
> Pipeline Overview
> HMPL-004
> HMPL-011
> HMPL-012
> HMPL-013
> HMPL-813
Research & Development
> Drug Discovery Research
> Drug Development
> Facility and Capacity
Collaborations
> Overview
> Existing Partnerships
Media
> Key Facts
> Press Releases
> Featured Articles
Careers
Contacts
About Us
Hutchison MediPharma is an internationally focused biotechnology company focused on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases.
Product Pipeline
Hutchison MediPharma has a pipeline of clinical and preclinical therapeutics for cancer and autoimmune diseases.
Latest News
05/25/2010
Hutchison MediPharma and the Committee of Anti-Cancer Agent Successfully Jointly Hold the First Targeted Anti-Cancer Drug Research and Development Symposium
05/06/2010
Receives SFDA IND Approval and Begins Phase I Clinical Trial of Sulfatinib for the Treatment of Cancer
Recent Awards
